Related Experiment Video
Updated: Dec 9, 2025

04:41
Isolation, Culture, and Characterization of Primary Dermal Fibroblasts from Human Keloid Tissue
Published on: July 28, 2023
3.1K
Keloids: a review of therapeutic management
Samuel F Ekstein1, Saranya P Wyles2, Steven L Moran3,4
1Mayo Clinic Alix School of Medicine, Mayo Clinic, Rochester, MN, USA.
International Journal of Dermatology
|September 9, 2020
Summary
Keloid scars result from excessive collagen. Current treatments have high recurrence, but combining therapies like lasers with steroids shows promise for better keloid management.
Area of Science:
- Dermatology
- Wound Healing
- Regenerative Medicine
Background:
- Keloid scars stem from abnormal fibroproliferative collagen responses and excessive extracellular matrix production.
- Existing treatments like intralesional steroids and surgical excision for keloids have high recurrence rates.
- Effective keloid management remains challenging due to the complex pathophysiology.
Purpose of the Study:
- To consolidate recent literature on keloid scar formation and treatment.
- To provide updated treatment recommendations for keloidal scar management.
- To offer insights for evidence-based clinical decision-making in patient care.
Main Methods:
- Conducted a literature search using PubMed and MEDLINE.
- Reviewed over 100 articles, including narrative reviews, systematic reviews, and meta-analyses.
- Focused on updated information regarding keloid incidence and treatment modalities.
Main Results:
- Keloid management requires a multimodal approach.
- No single gold standard treatment exists, but combination therapies show favorable results.
- Synergistic combinations, such as laser therapy with intralesional steroids or 5-fluorouracil with steroids, are promising.
Conclusions:
- Updated treatment guidelines for keloids emphasize multimodal and combination strategies.
- Novel therapies like autologous fat grafting and stem cell-based treatments warrant future investigation.
- Evidence-based approaches are crucial for optimizing patient-focused keloid management.
Related Concept Videos
Skin Cancer
5.6K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
5.6K
Clinical Applications of Epidermal Stem Cells
3.1K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
3.1K

